TLR3-driven IFN-β antagonizes STAT5-activating cytokines and suppresses innate type 2 response in the lung
Rinna Tei(WinnMed), Hirohito Kita(Mayo Clinic), Koji Matsumoto(WinnMed), Jyoti Lama(WinnMed), Koji Iijima(WinnMed), Takao Kobayashi(Hokkaido University), Elizabeth A. Jacobsen(WinnMed)
Cited by 16
Related Papers
IL-33–Responsive Lineage−CD25+CD44hi Lymphoid Cells Mediate Innate Type 2 Immunity and Allergic Inflammation in the Lungs
|The Journal of Immunology|2011|552
The Danger Signal, Extracellular ATP, Is a Sensor for an Airborne Allergen and Triggers IL-33 Release and Innate Th2-Type Responses
|The Journal of Immunology|2011|490
IL-33–activated dendritic cells induce an atypical TH2-type response
|Journal of Allergy and Clinical Immunology|2009|400
Enhanced innate type 2 immune response in peripheral blood from patients with asthma
|Journal of Allergy and Clinical Immunology|2014|379
Proteases Induce Production of Thymic Stromal Lymphopoietin by Airway Epithelial Cells through Protease-Activated Receptor-2
|The Journal of Immunology|2009|358